IPO and Fundraising - The company completed its initial public offering on February 23, 2024, selling 6,900,000 units at 10.00perunit,generatinggrossproceedsof69,000,000[92] - A private placement with DT Cloud Capital Corp. raised an additional 2,345,000fromthesaleof234,500unitsat10.00 per unit[92] - As of February 23, 2024, a total of 69,345,000fromtheIPOandprivateplacementwasdepositedinatrustaccountforpublicshareholders[92]−Thecompanyhasatotalof69,345,000 in net proceeds from its initial public offering and private placement, which will be used for its initial business combination[107] - The underwriters are entitled to a cash underwriting discount of 2.5% of the gross proceeds of the initial public offering, amounting to 1,725,000[116]BusinessCombination−Thecompanyhasa12−monthperiodfromtheIPOclosingtocompleteitsinitialbusinesscombination,extendableto24monthswithadditionalfunding[95]−AdefinitivebusinesscombinationagreementwasenteredintowithMaiusPharmaceuticalCo.,Ltd.onOctober22,2024[97]−ThecompanyenteredintoaBusinessCombinationAgreementonOctober22,2024,whichwillresultinbecomingawhollyownedsubsidiaryofPubco[119]−Thecompanyhascommittedtoprovidingpublicshareholderswithredemptionopportunitiesuponthecompletionofthebusinesscombination[94]−Thecompanyhastheoptiontoextendthebusinesscombinationdeadlinebydepositingadditionalfundsintothetrustaccount[95]FinancialPerformance−FortheninemonthsendedSeptember30,2024,thecompanyreportedanetincomeof1,633,003, primarily from dividend income of 2,171,443[115]−ForthethreemonthsendedSeptember30,2024,thecompanyachievedanetincomeof760,262, compared to a net loss of 5,000forthesameperiodin2023[114]−AsofSeptember30,2024,thecompanyhadcashatbankof167,526 and cash used in operating activities was 671,186[109]−Thecompanyincurredformationandoperatingcostsof538,462 for the nine months ended September 30, 2024[115] - The company issued an unsecured promissory note allowing borrowing up to 300,000,withaprincipalamountdueof0 as of September 30, 2024[110] - The company has a temporary advance of 70,000fromthesponsorasofSeptember30,2024,downfrom490,000 at the end of 2023[111] Risks and Challenges - The company is subject to risks from geopolitical instability, including the Russia-Ukraine conflict and tensions in the Middle East, which may impact market conditions[104] - The company may face challenges in finding a suitable business combination target due to economic uncertainties and capital market disruptions[105] - If the company fails to complete a business combination by the deadline, it will redeem public shares at a price of approximately $10.05 per share[94] Accounting and Estimates - The company has not identified any critical accounting estimates that could materially affect its financial statements[120]